Aerovate Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTE and other ETFs, options, and stocks.

About AVTE

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. 

CEO
Timothy P. Noyes
CEOTimothy P. Noyes
Employees
16
Employees16
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2018
Founded2018
Employees
16
Employees16

AVTE Key Statistics

Market cap
434.69M
Market cap434.69M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
163.41K
Average volume163.41K
High today
$17.78
High today$17.78
Low today
$15.99
Low today$15.99
Open price
$15.99
Open price$15.99
Volume
8.43K
Volume8.43K
52 Week high
$27.83
52 Week high$27.83
52 Week low
$7.74
52 Week low$7.74

AVTE Earnings

-$23.80
-$15.87
-$7.93
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.